News

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
Pfizer and Astellas’ Xtandi (enzalutamide) has improved overall survival (OS) in patients with non-metastatic ...
According to Pfizer, "Hundreds of millions of doses of the Pfizer-BioNTech COVID-19 vaccine have been administered globally, ...
Last month, during Cannes Lions, Netflix announced that its ad inventory will be available to buy programmatically via Yahoo ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
Pfizer Inc. (NYSE:PFE) is one of the 10 Best Non-Tech Stocks to Buy and Hold For 3 Years. On July 1, GlobalNewswire reported ...
Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years.
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...
One of the best known communications executives in corporate America, Susman worked at Pfizer for nearly two decades after ...
"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...
AbbVie has placed a high price on that potential, coughing up $700 million for a phase 1 candidate and offering up to $1.225 ...
Pfizer Inc. closed 18.77% short of its 52-week high of $31.54, which the company achieved on July 30th.